Future-Proof Oncology Trials: FDA Biomarkers, Trop-2 & Global IND
Practical Q&A for regulatory leads: navigate FDA biomarker pathways, Trop-2 trial strategy, global IND harmonization, and pharmacovigilance best practices with real trial examples.
Robert Maxwell
Oct 01, 2025
Trop-2 breast cancer
Decentralized diabetes studies
Oncology IND strategy
Hypertension safety reporting
